Antitumor effect on human gastric cancer and induction of apoptosis by vascular endothelial growth factor neutralizing antibody

Japanese Journal of Cancer Research

Volumn 90, Issue 7, 1999, Pages 794-800

  Kamiya, Kinji ^a   Konno, Hiroyuki ^a   Tanaka, Tatsuo ^a   Baba, Megumi ^a   Matsumoto, Keigo ^a   Sakaguchi, Takanori ^a   Yukita, Ayako ^b   Asano, Makoto ^b   Suzuki, Hideo ^b   Arai, Tomio ^c   Nakamura, Satoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Toagosei Co   (Japan)

^c Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology   (Japan)

Author keywords

Antiangiogenic therapy; Apoptosis; Microvessel density; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIBODY; MESSENGER RNA; MV 833; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR VASCULARIZATION;

EID: 0032779969     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00817.x     Document Type: Article

References (38)

1. Arai, T. and Kino, I. Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J. Pathol., 176, 37-44 (1995).
2. Kerr, J. F., Winterford, C. M. and Harmon, B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer, 73, 2013-2026 (1994).
3. Sen, S. and D'Incalci, M. Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett., 307, 122-127 (1992).
4. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78, 539-542 (1994).
5. Holmgren, L., O'Reilly, M. S. and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1, 149-153 (1995).
6. O'Reilly, M. S., Holmgren, L., Chen, C. and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med., 2, 689-692 (1996).
7. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R. and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277-285 (1997).
8. Ahmed, M. H., Konno, H., Nahar, L., Tanaka, T., Naito, Y., Nakamura, S. and Baba, S. The angiogenesis inhibitor TNP-470 (AGM-1470) improves long-term survival of rats with liver metastasis. J. Surg. Res., 64, 35-41 (1996).
9. Ahmed, M. H., Arai, T., Konno, H., Nahar, L., Tanaka, T., Izumiyama, N., Takubo, K., Nakamura, S. and Baba, S. Regression of metastatic liver tumors in rats treated with angiogenesis inhibitor TNP-470: occurrence of apoptosis and necrosis. Jpn. J. Cancer Res., 88, 977-981 (1997).
10. Folkman, J. and Klagsburn, M. Angiogenic factors. Science, 235, 442-447 (1987).
11. Ferrara, N. and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev., 18, 4-25 (1997).
12. Maeda, K., Chung, Y. S., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T. and Sowa, M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer, 77, 858-863 (1996).
13. Gasparini, G., Toi, M., Gion, M., Verderio, P., Dittadi, R., Hanatani, M., Matsubara, I., Vinante, O., Bonoldi, E., Boracchi, P., Gatti, C., Suzuki, H. and Tominaga, T. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl. Cancer Inst., 89, 139-147 (1997).
14. Kim, K. J., Li, B., Houck, K., Winer, J. and Ferrara, N. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors, 7, 53-64 (1992).
15. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S. and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, 362, 841-844 (1993).
16. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A. and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest., 95, 1789-1797 (1995).
17. Asano, M., Yukita, A., Matsumoto, T., Hanatani, M. and Suzuki, H. An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor activity in vivo. Hybridoma, 17, 185-190 (1998).
18. Kanai, T., Konno, H., Tanaka, T., Baba, M., Matsumoto, K., Nakamura, S., Yukita, A., Asano, M., Suzuki, H. and Baba, S. Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice. Int. J. Cancer, 77, 933-936 (1998).
19. Kanai, T., Konno, H., Tanaka, T., Matsumoto, K., Baba, M., Nakamura, S. and Baba, S. Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice. Int. J. Cancer, 71, 838-841 (1997).
20. Furukawa, T., Fu, X., Kubota, T., Watanabe, M., Kitajima, M. and Hoffman, R. M. Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res., 53, 1204-1208 (1993).
21. Tanaka, T., Konno, H., Matsuda, I., Nakamura, S. and Baba, S. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res., 55, 836-839 (1995).
22. Kerr, J. F., Wyllie, A. H. and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257 (1972).
23. Walker, N. I., Harmon, B. V., Gobe, G. C. and Kerr, J. F. Patterns of cell death. Methods Achiev. Exp. Pathol., 13, 18-54 (1988).
24. Sharkey, A. M., Charnock Jones, D. S., Boocock, C. A., Brown, K. D. and Smith, S. K. Expression of mRNA for vascular endothelial growth factor in human placenta. J. Reprod. Fertil., 99, 609-615 (1993).
25. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462 (1995).
26. Lowe, S. W., Ruley, H. E., Jacks, T. and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967 (1993).
27. Santana, P., Pena, L. A., Haimovitz Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon Cardo, C., Schuchman, E. H., Fuks, Z. and Kolesnick, R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell, 86, 189-199 (1996).
28. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82, 4-6 (1990).
29. Sim, B. K., O'Reilly, M. S., Liang, H., Fortier, A. H., He, W., Madsen, J. W., Lapcevich, R. and Nacy, C. A. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res., 57, 1329-1334 (1997).
30. Kusaka, M., Sudo, K., Matsutani, E., Kozai, Y., Marui, S., Fujita, T., Ingber, D. and Folkman, J. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br. J. Cancer, 69, 212-216 (1994).
31. Kumar, R. and Fidler, I. J. Angiogenic molecules and cancer metastasis. In Vivo, 12, 27-34 (1998).
32. Asano, M., Yukita, A., Matsumoto, T., Kondo, S. and Suzuki, H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res., 55, 5296-5301 (1995).
33. Ling, V., Luxenberg, D., Wang, J., Nickbarg, E., Leenen, P. J., Neben, S. and Kobayashi, M. Structural identification of the hematopoietic progenitor antigen ER-MP12 as the vascular endothelial adhesion molecule PECAM-1 (CD31). Eur. J. Immunol., 27, 509-514 (1997).
34. Shimizu, S., Eguchi, Y., Kamiike, W., Itoh, Y., Hasegawa, J., Yamabe, K., Otsuki, Y., Matsuda, H. and Tsujimoto, Y. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res., 56, 2161-2166 (1996).
35. Ikeda, H., Suzuki, Y., Suzuki, M., Koike, M., Tamura, J., Tong, J., Nomura, M. and Itoh, G. Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut, 42, 530-537 (1998).
36. Yoshimura, S., Banno, Y., Nakashima, S., Takenaka, K., Sakai, H., Nishimura, Y., Sakai, N., Shimizu, S., Eguchi, Y., Tsujimoto, Y. and Nozawa, Y. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation. J. Biol. Chem., 273, 6921-6927 (1998).
37. Vogt, M., Bauer, M. K., Ferrari, D. and Schulze Osthoff, K. Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO-1/Fas) ligand expression in microglial cells. FEBS Lett., 429, 67-72 (1998).
38. Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H. and Ferrara, N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol Chem., 271, 5638-5646 (1996).